Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 20:9:722943.
doi: 10.3389/fpubh.2021.722943. eCollection 2021.

Point of Care Testing for Infectious Disease in Europe: A Scoping Review and Survey Study

Affiliations

Point of Care Testing for Infectious Disease in Europe: A Scoping Review and Survey Study

Lucy Hocking et al. Front Public Health. .

Abstract

Background: Point of care testing (POCT) for infectious diseases is testing conducted near the patient. It allows clinicians to offer the most appropriate treatment more quickly. As POCT devices have increased in accuracy and become more cost-effective, their use has grown, but a systematic assessment of their use for clinical and public health management of infectious diseases in EU/EEA countries has not been previously undertaken. Methods: A scoping review of the literature on POCT in EU/ EEA countries as at November 2019, and a survey of key stakeholders. Results: 350 relevant articles were identified and 54 survey responses from 26 EU/EEA countries were analysed. POCT is available for a range of infectious diseases and in all countries responding to the survey (for at least one disease). POCT is commonly available for influenza, HIV/AIDS, Legionnaires' disease and malaria, where it is used in at least half of EU/EEA countries. While POCT has the potential to support many improvements to clinical care of infectious diseases (e.g., faster diagnosis, more appropriate use of antimicrobials), the results suggest POCT is infrequently used to support public health functions (e.g., disease surveillance and reporting). Conclusion: Although POCT is in use to some extent in all EU/EEA countries, the full benefits of POCT in wider public health functions have yet to be realised. Further research on barriers and facilitators to implementation is warranted.

Keywords: Europe; diagnostics; infectious diseases; near patient; near patient testing; point of care (POC); point of care (POC) diagnosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
PRISMA-ScR flow diagram for the scoping review.
Figure 2
Figure 2
Availability of POCT for infectious diseases and associated health conditions in EU/EEA countries.
Figure 3
Figure 3
POCT turnaround time by type of infectious disease.

References

    1. Brendish NJ, Poole S, Naidu VV, Mansbridge CT, Norton NJ, Wheeler H, et al. . Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study. Lancet Respir Med. (2020) 8:1192–200. 10.1016/S2213-2600(20)30454-9 - DOI - PMC - PubMed
    1. ISO . ISO 22870:2016 Point-of-care testing (POCT) - Requirements for quality and competence. Geneva: ISO; (2016).
    1. Larsson A, Greig-Pylypczuk R, Huisman A. The state of point-of-care testing: A European perspective. Ups J Med Sci. (2015) 120:1–10. 10.3109/03009734.2015.1006347 - DOI - PMC - PubMed
    1. Kumar Vashist S, Luppa PB, Yeo LY, Ozcan A, Luong JHT. Emerging technologies for next-generation point-of-care testing. Trends Biotechnol. (2015) 33:692–705. 10.1016/j.tibtech.2015.09.001 - DOI - PubMed
    1. Kozel TR, Burnham-Marusich AR. Point-of-Care Testing for Infectious Diseases: Past, Present, and Future. J Clin Microbiol. (2017) 55:2313. 10.1128/JCM.00476-17 - DOI - PMC - PubMed

Publication types